GZMB and COVID-19: Known markers of CD8+ T cell activation (T-bet, Ki-67, CD69, TOX, and GZMB) were significantly increased in baseline COVID-19 patients compared to HD (Fig. 2H), supporting our hypothesis that SARS-CoV-2 infection increases peripheral T cell activation.